The incidence of prosthetic valve endocarditis is 2-4 %; in most cases
the involved organisms are Staphylococcus epidermidis and Staph. aure
us. Fungal endocarditis is much less common (incidence <0.1%), but it
is often fatal, with a long-term mortality rate of 90-100%. Most funga
l endocarditis cases occur after aortic valvular surgery, due to Candi
da sp. Late-onset symptoms, long-term development and aggressive natur
e of the fungus makes its eradication complicated and treatment diffic
ult. Fungal valvular mycoses produce systemic embolization and cause s
erious perioperative bleeding on resection of infected tissue. Usually
surgery includes aortic root replacement with an aortic homograft con
duit after radical debridement, to attain local sterilization. This re
port describes a patient with complex infection, requiring replacement
of an infected prosthetic valve with an aortic homograft conduit, agg
ressive and radical debridement of infected tissue, and reconstruction
using biologic tissues. The case demonstrates the importance of perio
perative and long-term antifungal treatment and presents a modified 'C
abrol procedure' to prevent critical intraoperative hemorrhage.